Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Endocrinol (Lausanne) ; 15: 1394383, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38887271

RESUMO

Background: Serum testosterone is intrinsically associated to cardiovascular disease. Our aim is to explore the relationship between the recently updated cardiovascular health measurement, known as Life's Essential 8 (LE8), and the prevalence of testosterone deficiency (TD) in adult males in the United States. Methods: Study data was obtained from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2016. A weighted multivariate logistic regression model was applied to evaluate the correlation between LE8 and testosterone deficiency. Restricted Cubic Spline (RCS) was employed to explore its non-linear relationship. In addition, a stratified analysis was conducted. Results: The final analysis included 2332 participants from NHANES from 2011 to 2016. After adjusting for confounding factors, the odds ratios (ORs) and 95% confidence intervals (CIs) for testosterone deficiency in participants with moderate and higher LE8 scores compared to the lowest LE8 scores were 0.59 (0.38-0.92) and 0.38 (0.19-0.76), respectively. The results of subgroup analysis showed that LE8 score was significantly associated with TD among young and middle-aged participants. Conclusion: A lower LE8 score is related to a higher incidence of testosterone deficiency, especially in young and middle-aged men. Further research is necessary to explore the potential mechanisms between them.


Assuntos
Inquéritos Nutricionais , Testosterona , Humanos , Masculino , Testosterona/sangue , Testosterona/deficiência , Adulto , Pessoa de Meia-Idade , Estados Unidos/epidemiologia , Prevalência , Adulto Jovem , Idoso , Estudos Transversais , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/etiologia , Hipogonadismo/epidemiologia , Hipogonadismo/sangue
2.
Cardiol Young ; 34(4): 748-753, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37814585

RESUMO

BACKGROUND: Early diagnosis of acute coronary syndrome is more and more important because of its mortality and morbidity. Hypertension is one of the pathogenesis of acute coronary syndrome, which often leads to stenosis and ischaemia. Ischaemia-modified albumin is sensitive for the occurrence of ischaemia, which attracted us in the significance of ischaemia-modified albumin in patients with chest pain, especially patients complicated with hypertension. METHODS: In total, 200 patients with acute chest pain were included in the study. According to the diagnostic criteria, patients were divided into acute coronary syndrome group and non-ischaemic chest pain group. Cardiac biomarkers were measured with 30 minutes in emergency department, including cardiac troponin T, creatine kinase MB, and ischaemia-modified albumin. Receiver operating characteristic curve (ROC) analysis was used for the sensitivity and specificity of ischaemia-modified albumin in the early diagnosis of acute coronary syndrome. Comparisons between ischaemia-modified albumin and cardiac Troponin T were done between groups. RESULTS: The demographics in two groups were not significantly different in most aspects. Compared with non-ischaemic chest pain group, serum levels of ischaemia-modified albumin and cardiac Troponin T were significantly higher in acute coronary syndrome group. ROC analysis showed that ischaemia-modified albumin had a good sensitivity and specificity in early diagnosis of acute coronary syndrome. The level of ischaemia-modified albumin in acute coronary syndrome patients with hypertension was higher than that in non-ischaemic chest pain patients. CONCLUSIONS: In patients complained with acute chest pain, the serum measurement of ischaemia-modified albumin is potential valuable for the early diagnosis of acute coronary syndrome, especially combined with ECG. The serum level of ischaemia-modified albumin in acute coronary syndrome patients is significantly associated with hypertension.


Assuntos
Síndrome Coronariana Aguda , Hipertensão , Albumina Sérica Humana , Humanos , Síndrome Coronariana Aguda/complicações , Síndrome Coronariana Aguda/diagnóstico , Troponina T , Biomarcadores , Relevância Clínica , Albumina Sérica , Sensibilidade e Especificidade , Dor no Peito/diagnóstico , Dor no Peito/etiologia , Hipertensão/complicações , Hipertensão/diagnóstico , Isquemia
3.
Drug Dev Res ; 83(4): 1034-1046, 2022 06.
Artigo em Inglês | MEDLINE | ID: mdl-35277867

RESUMO

Preeclampsia (PE) is one of the most serious diseases during pregnancy. Circular RNAs (circRNAs) are strongly related to the occurrence of preeclampsia. Herein, we aimed to explore the potential role and mechanism of circRNA oligophrenin 1 (circ-OPHN1; hsa_circ_0007445) in PE. Quantitative real-time polymerase chain reaction (qPCR) and western blot were utilized to detect gene expression levels. The biological behaviors of trophoblast cells were determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT), flow cytometry, transwell, and wound healing methods. The binding relationship between microRNA-558 (miR-558) and circ-OPHN1 or thrombospondin 2 (THBS2) was validated via dual-luciferase reporter assay. Circ-OPHN1 and THBS2 levels were enhanced, while miR-558 level was declined in PE placental tissues. Circ-OPHN1 or THBS2 overexpression hindered the proliferation, migration, and invasion of trophoblast cells. In addition, circ-OPHN1 sequestered miR-558 to regulate THBS2 expression, thereby repressing the growth and mobility of trophoblast cells. Circ-OPHN1 inhibited trophoblast cell proliferation, migration, and invasion through mediating miR-558/THBS2 axis, providing a novel pathway for PE pathogenesis.


Assuntos
MicroRNAs , Pré-Eclâmpsia , RNA Circular , Trombospondinas , Trofoblastos , Movimento Celular , Proliferação de Células , Proteínas do Citoesqueleto/metabolismo , Feminino , Proteínas Ativadoras de GTPase/metabolismo , Humanos , MicroRNAs/genética , Proteínas Nucleares/metabolismo , Placenta/metabolismo , Placenta/patologia , Pré-Eclâmpsia/genética , Gravidez , RNA Circular/genética , Trombospondinas/genética , Trombospondinas/metabolismo , Trofoblastos/metabolismo , Trofoblastos/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...